Global Asparaginase Market By Type (Escherichia Coli, Erwinia Chrysanthemi, And Pegylated), By Application (Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, And Other.

“Global Asparaginase Market” is the title of an upcoming report offered by Market.US. This comprehensive market research report on the asparaginase industry contains inputs, as well as information & data from both primary and secondary sources, that have been validated and verified by target market experts. Apart from critical data and other related information, the report also includes factors that could be or are potential restraints to market growth, present & future key trends, recourses that can be leveraged for potential market expansion in untapped regions or countries, as well as factors that are presently fueling growth in the asparaginase market. It also covers challenges or threats for new, as well as existing market entrants. The report presents a thorough study of revenues, key developments, strategies, historical data and information by major players that offer crucial perspectives/insights into various market scenarios. The global asparaginase market has been segmented on the basis of source, application, as well as regions and countries.

The Global was valued at UЅD $389.2 Мn in 2020, and is projected to register а САGR of 3.2% over the next 10 years.

Request Covid - 19 Impact

Overview:

Asparaginase is an enzyme that is used as a medication and in food manufacturing. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia, non-Hodgkin’s lymphoma, and acute myeloid leukemia. It is delivered via an injection through a vein, muscle or below the skin.

Dynamics:

The increasing usage of asparaginase in the treatment of cancer as it inhibits protein synthesis, thereby reducing the growth of cancerous cells in the human body, is a major factor that is expected to continue to fuel the revenue growth of the global asparaginase market in the foreseeable future. Growing investments being made by government and private organizations towards R&D activities related to cancer treatment methodologies, as well as several key industry players resorting to strategic mergers & acquisitions to strengthen their market position and to improve their R&D capabilities, are factors anticipated to influence future market growth for this respective industry.

Asparagine is included in minute amounts to processed food as a means of reducing the presence of carcinogenic elements. This increasing usage is slated to contribute to the future market growth of this industry. The steady increase in the disposable incomes of individuals across the world is allowing them spend more on purchasing processed foods. These factors also slated to have a positive effect on the revenue growth of global asparaginase market in the years to come.

In light of the recent COVID-19 outbreak, the manufacturing and supply-chain operations of key industry players has been temporarily halted or are functioning with minimal workforces. This factor is slated to have a significant impact on end-use industries, and thereby subsequent revenue growth of this global market in the near future

Segmentation of the global asparaginase market is as follows:

On the basis of source, the Escherichia coli segment accounted for the maximum number of revenue shares (57.7%) of the global asparaginase market in 2020, and is slated to index a CAGR of 3.4% over the next 10 years. The erwinia chrysanthemi segment also made up for considerable revenue shares of this global market in 2020.

In terms of application, the acute lymphoblastic leukemia segment accounted for the majority revenue shares (54.8%) of the global asparaginase market in 2020, and is slated to register the highest CAGR of 3.8%, with an attractiveness index of 7.1, over the next 10 years. The acute myeloid leukemia segment is also anticipated to expand at a considerable rate of revenue growth in the coming years.

Regional Segmentation and Analysis:

North America accounted for the majority revenue shares (43.7%) of the global asparaginase market in 2020, and is slated to index a high rate of revenue growth over the next decade. The markets in Europe accounted for the second-most number of revenue shares (USD $103.2 Mn) of this global market in 2020.

Segmentation of the Global Asparaginase Market:

Segmentation by Source:

• Escherichia Coli
• Erwinia Chrysanthemi
• Pegylated

Segmentation by Application:

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Other Applications

Segmentation by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

 Key players profiled in the market report are:

• Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (Mingxing Pharmaceutical)
• Kyowa Kirin Co. Ltd
• Jazz Pharmaceuticals Inc.
• Novozymes A/S
• Medac GmbH
• Changzhou Qianhong Bio-Pharma Co. Ltd.
• Taj Pharma Group
• United Biotech Pvt. Ltd.
• BioVendor Group
• JSN Chemicals Ltd.

For the Asparaginase Market research study, the following years have been considered to estimate the market size: